Stock listing
Beyondspring, Inc.
Selected listing: BYSI · NASDAQ · USD · US
Beyondspring, Inc. (NASDAQ:BYSI), Health Technology. Latest release Sep 29, 2026: BeyondSpring Announces FDA Fast Track Designation for Plinabulin in Post-ICI…
- Ticker
- NASDAQ:BYSI
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Beyondspring, Inc.
Beyondspring, Inc. is a public company traded under the ticker BYSI in the American market. Beyondspring focuses on developing innovative solutions in its industry, contributing to advancements in healthcare.
Latest news from Beyondspring, Inc.
BeyondSpring Announces FDA Fast Track Designation for Plinabulin in Post-ICI Non-Squamous NSCLC and Strategic Transaction to Advance Global Phase 3 DUBLIN-4 Trial Toward Planned Interim Analysis
September 28, 2026
BeyondSpring : FDA Fast Track designation represents an important regulatory milestone for the Plinabulin and docetaxel combination as an anticancer regimen in…
September 29, 2026
BeyondSpring Reports Second-Quarter 2026 Financial Results and Provides Corporate Update
August 14, 2026
BeyondSpring Announces Leadership Transition to Deliver Focused Execution on Its Confirmatory DUBLIN-4 Program and Long-Term Value
June 3, 2026
BeyondSpring Presents the Latest Update of a Phase 2 Study Demonstrating Durable Clinical Benefit of Pembrolizumab Plus Plinabulin/Docetaxel in Metastatic NSCLC After Progression on First-Line Immune Checkpoint Inhibitor Therapy at ASCO 2026
June 2, 2026